Skip to main content
. 2017 May 31;8(31):51994–52005. doi: 10.18632/oncotarget.18317

Table 2. Meta-analysis results of the associations between rs2241766 and rs1501299 polymorphisms in ADIPOQ gene and CAD risk in T2DM patients.

Genetic model NO. of studies OR[95%CI] Pmeta-analysis Bon FDR I2 (%) Paheterogeneity Statistical method
rs2241766
G VS T 12 1.18 [0.89, 1.56] 0.260 1.000 0.613 80.00 0.000 Random
GG VS GT+TT 12 1.21 [0.56, 2.61] 0.630 1.000 0.630 81.00 0.000 Random
GG+GT VS TT 12 1.11 [0.88, 1.39] 0.390 1.000 0.613 68.00 0.000 Random
GT VS TT 12 1.08 [0.86, 1.37] 0.490 1.000 0.613 52.00 0.030 Random
GG VS TT 12 1.33 [0.69, 2.55] 0.400 1.000 0.613 72.00 0.000 Random
rs1501299
T VS G 10 0.86 [0.76, 0.98] 0.020 0.100 0.033 46.00 0.060 Fixed
TT VS TG+GG 10 0.40 [0.22, 0.71] 0.002 0.010 0.005 84.00 0.000 Random
TT+TG VS GG 10 0.95 [0.78, 1.16] 0.600 1.000 0.600 63.00 0.003 Random
TG VS GG 10 0.95 [0.79, 1.13] 0.530 1.000 0.600 45.00 0.070 Fixed
TT VS GG 10 0.67 [0.54, 0.83] 0.000 0.002 0.002 36.00 0.120 Fixed

OR= odd ratio; CI= confidence interval.

a P value for between-study heterogeneity based on Q test;Bon= p value in Bonferroni test; FDR= false discovery rate.

Significant results are marked in bold.